Potential number of human cases of H5N1 avian influenza in Egypt
Abstract
H5N1 is one of the avian influenza virus subtypes that has the potential to evolve into a global pandemic that could cause millions of human deaths and great economic losses. Cases involving humans have occurred in 15 countries. Costly interventions have been used by governments and health organisations. Thus, a challenging question arises regarding how many cases of the disease may actually have been prevented as a result of such interventions. This paper answers such a question by applying a statistical model to the 2006-January 2009 outbreak in Egypt. Egypt was chosen as it had the highest number of human avian influenza cases outside Asia, and the second highest number in that period worldwide. Brookmeyer and Blades' statistical model was applied. The sensitivities of the estimated number of human cases and exposure dates to the assumed incubation period, the delay in intervention and the coverage/effectiveness of the intervention were investigated. In the absence of intervention, it appears that the outbreak could have been approximately 1.5 times as large, but it is unlikely it would have exceeded 150 cases. The results underscore the importance of early detection of an outbreak and intervention, together with effective p...Continue Reading
References
Citations
Related Concepts
Related Feeds
Antivirals
Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.
Anthrax Vaccines
Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.
Anthrax
Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.
Antivirals (ASM)
Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.
Anthrax Vaccines (ASM)
Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.